valsartan/amlodipine

DRUG7 trials

Sponsors

Novartis, LG Life Sciences

Conditions

HypertensionLower Leg EdemaOrthostatic HypertensionPrimary Hypertension

Phase 3

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

CompletedNCT00171535

NovartisHypertension

Start: 2004-10-31End: 2005-04-30Updated: 2011-11-08

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

CompletedNCT00171002

NovartisHypertension

Start: 2004-11-30End: 2005-06-30Updated: 2023-12-14

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

CompletedNCT00170963

NovartisHypertension

Start: 2004-10-31End: 2005-06-30Updated: 2017-05-17

Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

CompletedNCT00548067

NovartisHypertension

Start: 2007-09-30End: 2008-03-31Updated: 2010-09-27

Phase 4

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

CompletedNCT01167153

NovartisHypertension

Start: 2010-05-31End: 2011-04-30Updated: 2012-06-01

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

CompletedNCT01241487

NovartisPrimary Hypertension

Start: 2009-02-28End: 2011-01-31Target: 150Updated: 2017-02-23

Unknown Phase

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

LG Life SciencesLower Leg Edema, Orthostatic Hypertension

Start: 2014-07-31End: 2016-11-30Target: 2001Updated: 2016-04-19

Related Papers

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.

2009-11-0119 citations

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy.

2009-02-0116 citations